Dyne Therapeutics, Inc. 8-K

What Happened

• On March 2, 2026, Dyne Therapeutics, Inc. (DYN) announced its financial results for the year ended December 31, 2025 via a press release. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition).
• The Form 8-K states the information (including Exhibit 99.1) is being furnished, not “filed,” and therefore is not subject to Section 18 liability under the Securities Exchange Act and is not incorporated by reference into other filings except where expressly stated.

Key Details

• Filing date: March 2, 2026.
• Reporting period covered: Year ended December 31, 2025.
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• Disclosure status: Information furnished (not filed) — limited incorporation and liability per the filing.

Why It Matters

• This filing signals Dyne has released its 2025 earnings/financial results; those results (revenue, net income or loss, cash position, and any guidance) can be material to the company’s valuation and near-term stock performance.
• Retail investors should read the attached press release (Exhibit 99.1) or the company’s full earnings materials to see the specific figures and management commentary. The 8-K itself provides the formal notice of the release and the legal status of the disclosure.